TU04
Using SASŪ ODS to Enhance Clinical Data Summaries: Meeting eSub Guidelines
Steven Light, DataCeutics, Inc.
Kathleen Greene, Genzyme Corporation

SAS programmers in the pharmaceuticals industry are aware that the Food and Drug Administration (FDA) has raised the bar for presentation of summary tables and listings used as part of electronic submissions (esub). Guidelines for font selection, font siz e, and margins have made traditional text file output somewhat more challenging to work with. Fortunately for us, the new guidelines have coincided with the SAS Institute's implementation of ODS, which provides the ability to both greatly enhance the ap pearance of tabular output and to meet the esub guidelines. This presentation will provide an introduction to use of ODS in generating tabular reports (to RTF and PDF destinations) with a focus on the esub guidelines and the advantages of using ODS over l isting-mode output.